Eloxx Pharmaceuticals
ELOX18.4300.11% ( -0.020 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Eloxx Pharmaceuticals(ELOX) the EBIT is -3.795 M (-210.6%);the EPS is -0.857 (+82.66%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B210.56%
----
----
EPS
-0.856582.66%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf